Shoji Katsuda

Reduction of Serum Ubiquinol-10 and Ubiquinone-10 Levels by Atorvastatin in Hypercholesterolemic Patients

Hiroshi Mabuchi, Toshinori Higashikata, Masa‐aki Kawashiri et al. · Journal of Atherosclerosis and Thrombosis · 2005 · 117 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Characterization of Autosomal Dominant Hypercholesterolemia Caused by <i>PCSK9</i> Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody

Paul N. Hopkins, Joep C. Defesche, Sigrid W. Fouchier et al. · Circulation Cardiovascular Genetics · 2015 · 110 citations · Full text

Life Sciences, Genetics, Pharmacotherapy +17

Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: A randomized double-blind study

Hiroshi Mabuchi, Atsushi Nohara, Junji Kobayashi et al. · Atherosclerosis · 2007 · 99 citations

Life Sciences, Nutritional Sciences, Pharmacotherapy +12

The E32K variant of PCSK9 exacerbates the phenotype of familial hypercholesterolaemia by increasing PCSK9 function and concentration in the circulation

Tohru Noguchi, Shoji Katsuda, Masa‐aki Kawashiri et al. · Atherosclerosis · 2009 · 76 citations

Life Sciences, Genetics, Molecular Genetics +10

ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjects

Kenji Miwa, Akihiro Inazu, Junji Kobayashi et al. · Clinical Science · 2005 · 49 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17